Keywords: Merck & Co, R&D, Investment, China

Merck & Co commits $1.5 billion to R&D in China over next five years

Article | 07 December 2011

Print This

Adding to the flow of pharmaceutical investment into the BRIC (Brazil, Russia, India and China) countries, US drug giant Merck & ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in